CME Cme Group Inc

Price (delayed)

$209.505

Market cap

$75.42B

P/E Ratio

23.62

Dividend/share

$9.7

EPS

$8.87

Enterprise value

$166.13B

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
The company's net income rose by 20% YoY and by 6% QoQ
The EPS is up by 20% year-on-year and by 6% since the previous quarter
The debt has declined by 32% year-on-year but it has grown by 3.3% since the previous quarter
The equity has declined by 5% since the previous quarter
CME's quick ratio is down by 2.9% since the previous quarter

Key stats

What are the main financial stats of CME
Market
Shares outstanding
359.99M
Market cap
$75.42B
Enterprise value
$166.13B
Valuations
Price to book (P/B)
2.82
Price to sales (P/S)
13.48
EV/EBIT
38.52
EV/EBITDA
35.61
EV/Sales
29.78
Earnings
Revenue
$5.58B
EBIT
$4.31B
EBITDA
$4.67B
Free cash flow
$3.38B
Per share
EPS
$8.87
Free cash flow per share
$9.41
Book value per share
$74.27
Revenue per share
$15.54
TBVPS
$275.71
Balance sheet
Total assets
$129.71B
Total liabilities
$102.97B
Debt
$93.62B
Equity
$26.74B
Working capital
$1.47B
Liquidity
Debt to equity
3.5
Current ratio
1.02
Quick ratio
1
Net debt/EBITDA
19.44
Margins
EBITDA margin
83.6%
Gross margin
100%
Net margin
57.8%
Operating margin
61.6%
Efficiency
Return on assets
2.2%
Return on equity
11.6%
Return on invested capital
3.8%
Return on capital employed
11.9%
Return on sales
77.3%
Dividend
Dividend yield
4.63%
DPS
$9.7
Payout ratio
109.4%

CME stock price

How has the Cme Group stock price performed over time
Intraday
-1.53%
1 week
-0.75%
1 month
-3.79%
1 year
9.27%
YTD
-0.52%
QTD
-2.69%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$5.58B
Gross profit
$5.58B
Operating income
$3.44B
Net income
$3.23B
Gross margin
100%
Net margin
57.8%
The company's net income rose by 20% YoY and by 6% QoQ
The operating income is up by 14% YoY and by 6% QoQ
CME's revenue is up by 11% year-on-year and by 4.3% since the previous quarter
The gross profit has increased by 11% YoY and by 4.3% from the previous quarter

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
P/E
23.62
P/B
2.82
P/S
13.48
EV/EBIT
38.52
EV/EBITDA
35.61
EV/Sales
29.78
The EPS is up by 20% year-on-year and by 6% since the previous quarter
CME's P/E is 18% below its 5-year quarterly average of 29.1
CME's price to book (P/B) is 10% higher than its 5-year quarterly average of 2.6 and 10% higher than its last 4 quarters average of 2.6
The equity has declined by 5% since the previous quarter
CME's revenue is up by 11% year-on-year and by 4.3% since the previous quarter
The P/S is 3.6% lower than the 5-year quarterly average of 14.2 but 2.9% higher than the last 4 quarters average of 13.3

Efficiency

How efficient is Cme Group business performance
The ROIC has soared by 58% YoY and by 15% from the previous quarter
Cme Group's return on assets has surged by 57% YoY and by 10% QoQ
Cme Group's return on equity has increased by 21% YoY and by 6% QoQ
The return on sales is up by 6% year-on-year

Dividends

What is CME's dividend history
DPS
$9.7
Dividend yield
4.63%
Payout ratio
109.4%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 26% more than its total liabilities
Cme Group's total liabilities has decreased by 30% YoY but it has increased by 6% QoQ
Cme Group's total assets has decreased by 26% YoY but it has increased by 3.3% from the previous quarter
The debt has declined by 32% year-on-year but it has grown by 3.3% since the previous quarter
The debt to equity has contracted by 32% YoY but it has grown by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.